TrialBMC pharmacology & toxicology2017

The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia.

Moo-Yong Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.